Engineered Transaminases for Stable Chiral Tryptamine Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing chiral α-substituted tryptamine and tryptamine analogs are time-consuming, require harsh reaction conditions, and are limited by complex synthetic routes, making them inefficient and costly.
Innovation Solution
Engineered transaminase polypeptides with specific residue differences, such as at positions X31, X86, and X163, exhibit enhanced solvent and thermal stability, high stereoselectivity, and increased activity, enabling efficient conversion of prochiral ketone substrates to chiral tryptamine derivatives under mild conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If chemical synthetic routes are used to prepare chiral α-substituted tryptamine derivatives, then enantiomeric excess can be achieved, but the synthetic routes become complex and time-consuming
Solution Approach 1:
The patent replaces complex chemical synthetic routes with a biocatalytic system using engineered transaminase polypeptides. This substitution of chemical mechanisms with biological catalysis achieves high enantiomeric excess (up to 99% ee) while dramatically simplifying the synthetic pathway to a single enzymatic step, eliminating the need for multiple chemical reactions and separations
Solution Approach 2:
The patent employs protein engineering techniques to modify specific residue positions (X31, X86, X163) of the transaminase polypeptide, changing the biochemical parameters of the enzyme to achieve optimal stereoselectivity and catalytic activity for tryptamine derivative synthesis, thereby achieving high manufacturing precision through controlled parameter modification
2Reliability
If conventional transaminases are used, then the reaction can proceed, but the enzyme lacks sufficient solvent and thermal stability
Solution Approach 1:
The patent systematically modifies amino acid residues at positions X31, X86, and X163 of the transaminase polypeptide to enhance the enzyme's physical and chemical parameters, specifically improving solvent stability and thermal stability while maintaining or enhancing catalytic activity, thus achieving both reliability and productivity
3Manufacturing precision
If separation and isolation methods are used to obtain desired isomers, then chiral purity can be achieved, but the process becomes time-consuming
Solution Approach 1:
The patent replaces time-consuming separation and isolation procedures with a stereoselective biocatalytic reaction that directly produces the desired chiral isomer with high enantiomeric excess (up to 99% ee). The engineered transaminase enzyme inherently discriminates between enantiomers during catalysis, eliminating the need for subsequent separation steps and dramatically reducing process time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered transaminases achieve high enantiomeric excess and product tolerance, providing a cost-effective method for producing chiral tryptamine derivatives with improved efficiency and stability.
Implementation Method 1
engineered transaminase polypeptides... enabling efficient conversion of prochiral ketone substrates to chiral tryptamine derivatives
Data Source
AI summary
The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.